nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—Dry skin—Sorafenib—liver cancer	0.00524	0.0204	CcSEcCtD
Olopatadine—Nasopharyngitis—Sorafenib—liver cancer	0.00511	0.0199	CcSEcCtD
Olopatadine—Clomipramine—GSTP1—liver cancer	0.00478	0.272	CrCbGaD
Olopatadine—Keratitis—Epirubicin—liver cancer	0.00449	0.0175	CcSEcCtD
Olopatadine—Infestation—Sorafenib—liver cancer	0.0044	0.0171	CcSEcCtD
Olopatadine—Infestation NOS—Sorafenib—liver cancer	0.0044	0.0171	CcSEcCtD
Olopatadine—Epistaxis—Sorafenib—liver cancer	0.00415	0.0162	CcSEcCtD
Olopatadine—Keratitis—Doxorubicin—liver cancer	0.00415	0.0162	CcSEcCtD
Olopatadine—Stinging—Epirubicin—liver cancer	0.00359	0.014	CcSEcCtD
Olopatadine—Immune system disorder—Sorafenib—liver cancer	0.00357	0.0139	CcSEcCtD
Olopatadine—Mediastinal disorder—Sorafenib—liver cancer	0.00356	0.0139	CcSEcCtD
Olopatadine—Erythema—Sorafenib—liver cancer	0.00344	0.0134	CcSEcCtD
Olopatadine—Dysgeusia—Sorafenib—liver cancer	0.00337	0.0131	CcSEcCtD
Olopatadine—Stinging—Doxorubicin—liver cancer	0.00332	0.0129	CcSEcCtD
Olopatadine—Muscle spasms—Sorafenib—liver cancer	0.00331	0.0129	CcSEcCtD
Olopatadine—Cough increased—Epirubicin—liver cancer	0.00318	0.0124	CcSEcCtD
Olopatadine—Lacrimation increased—Epirubicin—liver cancer	0.00316	0.0123	CcSEcCtD
Olopatadine—Ulcer—Epirubicin—liver cancer	0.00308	0.012	CcSEcCtD
Olopatadine—Cough—Sorafenib—liver cancer	0.003	0.0117	CcSEcCtD
Olopatadine—Cough increased—Doxorubicin—liver cancer	0.00294	0.0114	CcSEcCtD
Olopatadine—Lacrimation increased—Doxorubicin—liver cancer	0.00292	0.0114	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00291	0.0113	CcSEcCtD
Olopatadine—Dermatitis contact—Epirubicin—liver cancer	0.00288	0.0112	CcSEcCtD
Olopatadine—Dry mouth—Sorafenib—liver cancer	0.00287	0.0112	CcSEcCtD
Olopatadine—Ulcer—Doxorubicin—liver cancer	0.00285	0.0111	CcSEcCtD
Olopatadine—Infection—Sorafenib—liver cancer	0.00279	0.0109	CcSEcCtD
Olopatadine—Nervous system disorder—Sorafenib—liver cancer	0.00275	0.0107	CcSEcCtD
Olopatadine—Skin disorder—Sorafenib—liver cancer	0.00273	0.0106	CcSEcCtD
Olopatadine—Dry eye—Epirubicin—liver cancer	0.00269	0.0105	CcSEcCtD
Olopatadine—Dermatitis contact—Doxorubicin—liver cancer	0.00266	0.0104	CcSEcCtD
Olopatadine—Dyspnoea—Sorafenib—liver cancer	0.0025	0.00975	CcSEcCtD
Olopatadine—Dry eye—Doxorubicin—liver cancer	0.00249	0.00968	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00242	0.00944	CcSEcCtD
Olopatadine—Fatigue—Sorafenib—liver cancer	0.00242	0.00942	CcSEcCtD
Olopatadine—Pain—Sorafenib—liver cancer	0.0024	0.00935	CcSEcCtD
Olopatadine—Nortriptyline—CYP2E1—liver cancer	0.0024	0.136	CrCbGaD
Olopatadine—Eye pain—Epirubicin—liver cancer	0.00234	0.0091	CcSEcCtD
Olopatadine—Gastrointestinal pain—Sorafenib—liver cancer	0.0023	0.00894	CcSEcCtD
Olopatadine—Abdominal pain—Sorafenib—liver cancer	0.00222	0.00864	CcSEcCtD
Olopatadine—Body temperature increased—Sorafenib—liver cancer	0.00222	0.00864	CcSEcCtD
Olopatadine—Eye pain—Doxorubicin—liver cancer	0.00216	0.00842	CcSEcCtD
Olopatadine—Hypersensitivity—Sorafenib—liver cancer	0.00207	0.00805	CcSEcCtD
Olopatadine—Asthenia—Sorafenib—liver cancer	0.00202	0.00784	CcSEcCtD
Olopatadine—Pruritus—Sorafenib—liver cancer	0.00199	0.00773	CcSEcCtD
Olopatadine—Dry skin—Epirubicin—liver cancer	0.00194	0.00753	CcSEcCtD
Olopatadine—Diarrhoea—Sorafenib—liver cancer	0.00192	0.00748	CcSEcCtD
Olopatadine—Nasopharyngitis—Epirubicin—liver cancer	0.00189	0.00735	CcSEcCtD
Olopatadine—Dizziness—Sorafenib—liver cancer	0.00186	0.00723	CcSEcCtD
Olopatadine—Influenza—Epirubicin—liver cancer	0.00183	0.0071	CcSEcCtD
Olopatadine—Dry skin—Doxorubicin—liver cancer	0.00179	0.00697	CcSEcCtD
Olopatadine—Vomiting—Sorafenib—liver cancer	0.00179	0.00695	CcSEcCtD
Olopatadine—Acepromazine—ALB—liver cancer	0.00177	0.101	CrCbGaD
Olopatadine—Rash—Sorafenib—liver cancer	0.00177	0.00689	CcSEcCtD
Olopatadine—Dermatitis—Sorafenib—liver cancer	0.00177	0.00689	CcSEcCtD
Olopatadine—Headache—Sorafenib—liver cancer	0.00176	0.00685	CcSEcCtD
Olopatadine—Nasopharyngitis—Doxorubicin—liver cancer	0.00175	0.0068	CcSEcCtD
Olopatadine—Thiothixene—ALB—liver cancer	0.0017	0.097	CrCbGaD
Olopatadine—Upper respiratory tract infection—Epirubicin—liver cancer	0.0017	0.0066	CcSEcCtD
Olopatadine—Influenza—Doxorubicin—liver cancer	0.00169	0.00657	CcSEcCtD
Olopatadine—Imipramine—CYP2E1—liver cancer	0.00167	0.0952	CrCbGaD
Olopatadine—Nausea—Sorafenib—liver cancer	0.00167	0.00649	CcSEcCtD
Olopatadine—Amitriptyline—CYP2E1—liver cancer	0.00166	0.0946	CrCbGaD
Olopatadine—Weight increased—Epirubicin—liver cancer	0.00166	0.00647	CcSEcCtD
Olopatadine—Infestation NOS—Epirubicin—liver cancer	0.00163	0.00633	CcSEcCtD
Olopatadine—Infestation—Epirubicin—liver cancer	0.00163	0.00633	CcSEcCtD
Olopatadine—Conjunctivitis—Epirubicin—liver cancer	0.00158	0.00616	CcSEcCtD
Olopatadine—Urinary tract infection—Epirubicin—liver cancer	0.00158	0.00616	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00157	0.00611	CcSEcCtD
Olopatadine—Weight increased—Doxorubicin—liver cancer	0.00154	0.00598	CcSEcCtD
Olopatadine—Epistaxis—Epirubicin—liver cancer	0.00154	0.00597	CcSEcCtD
Olopatadine—Sinusitis—Epirubicin—liver cancer	0.00153	0.00594	CcSEcCtD
Olopatadine—Infestation NOS—Doxorubicin—liver cancer	0.00151	0.00586	CcSEcCtD
Olopatadine—Infestation—Doxorubicin—liver cancer	0.00151	0.00586	CcSEcCtD
Olopatadine—Rhinitis—Epirubicin—liver cancer	0.00146	0.0057	CcSEcCtD
Olopatadine—Conjunctivitis—Doxorubicin—liver cancer	0.00146	0.0057	CcSEcCtD
Olopatadine—Urinary tract infection—Doxorubicin—liver cancer	0.00146	0.0057	CcSEcCtD
Olopatadine—Hypoaesthesia—Epirubicin—liver cancer	0.00145	0.00566	CcSEcCtD
Olopatadine—Pharyngitis—Epirubicin—liver cancer	0.00145	0.00564	CcSEcCtD
Olopatadine—Epistaxis—Doxorubicin—liver cancer	0.00142	0.00553	CcSEcCtD
Olopatadine—Sinusitis—Doxorubicin—liver cancer	0.00141	0.0055	CcSEcCtD
Olopatadine—Visual impairment—Epirubicin—liver cancer	0.00141	0.00548	CcSEcCtD
Olopatadine—Eye disorder—Epirubicin—liver cancer	0.00137	0.00531	CcSEcCtD
Olopatadine—Rhinitis—Doxorubicin—liver cancer	0.00136	0.00527	CcSEcCtD
Olopatadine—Clomipramine—ALB—liver cancer	0.00135	0.0767	CrCbGaD
Olopatadine—Hypoaesthesia—Doxorubicin—liver cancer	0.00135	0.00524	CcSEcCtD
Olopatadine—Pharyngitis—Doxorubicin—liver cancer	0.00134	0.00522	CcSEcCtD
Olopatadine—Immune system disorder—Epirubicin—liver cancer	0.00132	0.00514	CcSEcCtD
Olopatadine—Mediastinal disorder—Epirubicin—liver cancer	0.00132	0.00512	CcSEcCtD
Olopatadine—Nortriptyline—ALB—liver cancer	0.00132	0.0749	CrCbGaD
Olopatadine—Visual impairment—Doxorubicin—liver cancer	0.0013	0.00507	CcSEcCtD
Olopatadine—Erythema—Epirubicin—liver cancer	0.00127	0.00495	CcSEcCtD
Olopatadine—Eye disorder—Doxorubicin—liver cancer	0.00126	0.00492	CcSEcCtD
Olopatadine—Dysgeusia—Epirubicin—liver cancer	0.00125	0.00485	CcSEcCtD
Olopatadine—Back pain—Epirubicin—liver cancer	0.00123	0.00479	CcSEcCtD
Olopatadine—Muscle spasms—Epirubicin—liver cancer	0.00122	0.00476	CcSEcCtD
Olopatadine—Immune system disorder—Doxorubicin—liver cancer	0.00122	0.00475	CcSEcCtD
Olopatadine—Mediastinal disorder—Doxorubicin—liver cancer	0.00122	0.00474	CcSEcCtD
Olopatadine—Vision blurred—Epirubicin—liver cancer	0.0012	0.00467	CcSEcCtD
Olopatadine—Ill-defined disorder—Epirubicin—liver cancer	0.00118	0.00459	CcSEcCtD
Olopatadine—Erythema—Doxorubicin—liver cancer	0.00118	0.00458	CcSEcCtD
Olopatadine—Dysgeusia—Doxorubicin—liver cancer	0.00115	0.00449	CcSEcCtD
Olopatadine—Malaise—Epirubicin—liver cancer	0.00115	0.00446	CcSEcCtD
Olopatadine—Back pain—Doxorubicin—liver cancer	0.00114	0.00443	CcSEcCtD
Olopatadine—Muscle spasms—Doxorubicin—liver cancer	0.00113	0.0044	CcSEcCtD
Olopatadine—Cough—Epirubicin—liver cancer	0.00111	0.00432	CcSEcCtD
Olopatadine—Vision blurred—Doxorubicin—liver cancer	0.00111	0.00432	CcSEcCtD
Olopatadine—Ill-defined disorder—Doxorubicin—liver cancer	0.00109	0.00425	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00108	0.00419	CcSEcCtD
Olopatadine—Discomfort—Epirubicin—liver cancer	0.00107	0.00416	CcSEcCtD
Olopatadine—Malaise—Doxorubicin—liver cancer	0.00106	0.00413	CcSEcCtD
Olopatadine—Dry mouth—Epirubicin—liver cancer	0.00106	0.00412	CcSEcCtD
Olopatadine—Oedema—Epirubicin—liver cancer	0.00104	0.00404	CcSEcCtD
Olopatadine—Infection—Epirubicin—liver cancer	0.00103	0.00401	CcSEcCtD
Olopatadine—Cough—Doxorubicin—liver cancer	0.00103	0.004	CcSEcCtD
Olopatadine—Nervous system disorder—Epirubicin—liver cancer	0.00102	0.00396	CcSEcCtD
Olopatadine—Skin disorder—Epirubicin—liver cancer	0.00101	0.00392	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000995	0.00387	CcSEcCtD
Olopatadine—Discomfort—Doxorubicin—liver cancer	0.00099	0.00385	CcSEcCtD
Olopatadine—Dry mouth—Doxorubicin—liver cancer	0.00098	0.00381	CcSEcCtD
Olopatadine—Oedema—Doxorubicin—liver cancer	0.00096	0.00374	CcSEcCtD
Olopatadine—Infection—Doxorubicin—liver cancer	0.000954	0.00371	CcSEcCtD
Olopatadine—Nervous system disorder—Doxorubicin—liver cancer	0.000942	0.00367	CcSEcCtD
Olopatadine—Skin disorder—Doxorubicin—liver cancer	0.000933	0.00363	CcSEcCtD
Olopatadine—Dyspnoea—Epirubicin—liver cancer	0.000925	0.0036	CcSEcCtD
Olopatadine—Somnolence—Epirubicin—liver cancer	0.000923	0.00359	CcSEcCtD
Olopatadine—Amitriptyline—ALB—liver cancer	0.000914	0.052	CrCbGaD
Olopatadine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000896	0.00349	CcSEcCtD
Olopatadine—Fatigue—Epirubicin—liver cancer	0.000895	0.00348	CcSEcCtD
Olopatadine—Pain—Epirubicin—liver cancer	0.000888	0.00345	CcSEcCtD
Olopatadine—Dyspnoea—Doxorubicin—liver cancer	0.000856	0.00333	CcSEcCtD
Olopatadine—Feeling abnormal—Epirubicin—liver cancer	0.000855	0.00333	CcSEcCtD
Olopatadine—Somnolence—Doxorubicin—liver cancer	0.000854	0.00332	CcSEcCtD
Olopatadine—Gastrointestinal pain—Epirubicin—liver cancer	0.000849	0.0033	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000829	0.00323	CcSEcCtD
Olopatadine—Fatigue—Doxorubicin—liver cancer	0.000828	0.00322	CcSEcCtD
Olopatadine—Pain—Doxorubicin—liver cancer	0.000821	0.0032	CcSEcCtD
Olopatadine—Abdominal pain—Epirubicin—liver cancer	0.000821	0.00319	CcSEcCtD
Olopatadine—Body temperature increased—Epirubicin—liver cancer	0.000821	0.00319	CcSEcCtD
Olopatadine—Feeling abnormal—Doxorubicin—liver cancer	0.000791	0.00308	CcSEcCtD
Olopatadine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000785	0.00306	CcSEcCtD
Olopatadine—Hypersensitivity—Epirubicin—liver cancer	0.000765	0.00298	CcSEcCtD
Olopatadine—Abdominal pain—Doxorubicin—liver cancer	0.000759	0.00296	CcSEcCtD
Olopatadine—Body temperature increased—Doxorubicin—liver cancer	0.000759	0.00296	CcSEcCtD
Olopatadine—Asthenia—Epirubicin—liver cancer	0.000745	0.0029	CcSEcCtD
Olopatadine—Pruritus—Epirubicin—liver cancer	0.000734	0.00286	CcSEcCtD
Olopatadine—Diarrhoea—Epirubicin—liver cancer	0.00071	0.00276	CcSEcCtD
Olopatadine—S100A12—Immune System—ABL1—liver cancer	0.000708	0.000976	CbGpPWpGaD
Olopatadine—Hypersensitivity—Doxorubicin—liver cancer	0.000708	0.00275	CcSEcCtD
Olopatadine—S100B—Innate Immune System—PIK3CD—liver cancer	0.000706	0.000973	CbGpPWpGaD
Olopatadine—S100B—Immune System—PRKCE—liver cancer	0.000704	0.00097	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—PIK3CA—liver cancer	0.000697	0.000961	CbGpPWpGaD
Olopatadine—Asthenia—Doxorubicin—liver cancer	0.000689	0.00268	CcSEcCtD
Olopatadine—Dizziness—Epirubicin—liver cancer	0.000686	0.00267	CcSEcCtD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00068	0.000937	CbGpPWpGaD
Olopatadine—Pruritus—Doxorubicin—liver cancer	0.00068	0.00264	CcSEcCtD
Olopatadine—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000673	0.000927	CbGpPWpGaD
Olopatadine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000671	0.000925	CbGpPWpGaD
Olopatadine—S100B—Immune System—ABL1—liver cancer	0.00067	0.000923	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—RAF1—liver cancer	0.000666	0.000919	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HGF—liver cancer	0.000666	0.000918	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000664	0.000915	CbGpPWpGaD
Olopatadine—Vomiting—Epirubicin—liver cancer	0.00066	0.00257	CcSEcCtD
Olopatadine—S100A12—Immune System—CD8A—liver cancer	0.000659	0.000908	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CSF2—liver cancer	0.000659	0.000908	CbGpPWpGaD
Olopatadine—Diarrhoea—Doxorubicin—liver cancer	0.000657	0.00256	CcSEcCtD
Olopatadine—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000656	0.000904	CbGpPWpGaD
Olopatadine—Rash—Epirubicin—liver cancer	0.000654	0.00255	CcSEcCtD
Olopatadine—Dermatitis—Epirubicin—liver cancer	0.000654	0.00254	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—PIK3CB—liver cancer	0.000651	0.000897	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—MTOR—liver cancer	0.000651	0.000897	CbGpPWpGaD
Olopatadine—Headache—Epirubicin—liver cancer	0.00065	0.00253	CcSEcCtD
Olopatadine—Dizziness—Doxorubicin—liver cancer	0.000635	0.00247	CcSEcCtD
Olopatadine—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000633	0.000872	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—RAF1—liver cancer	0.00063	0.000869	CbGpPWpGaD
Olopatadine—S100B—Immune System—HGF—liver cancer	0.00063	0.000868	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000625	0.000862	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ADAM17—liver cancer	0.000625	0.000861	CbGpPWpGaD
Olopatadine—S100B—Immune System—CSF2—liver cancer	0.000623	0.000858	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD8A—liver cancer	0.000623	0.000858	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000617	0.00085	CbGpPWpGaD
Olopatadine—Nausea—Epirubicin—liver cancer	0.000617	0.0024	CcSEcCtD
Olopatadine—S100B—Innate Immune System—MTOR—liver cancer	0.000615	0.000848	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PIK3CB—liver cancer	0.000615	0.000848	CbGpPWpGaD
Olopatadine—Vomiting—Doxorubicin—liver cancer	0.000611	0.00238	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—CDKN1B—liver cancer	0.000611	0.000842	CbGpPWpGaD
Olopatadine—Rash—Doxorubicin—liver cancer	0.000606	0.00236	CcSEcCtD
Olopatadine—Dermatitis—Doxorubicin—liver cancer	0.000605	0.00235	CcSEcCtD
Olopatadine—Headache—Doxorubicin—liver cancer	0.000602	0.00234	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—PSMD10—liver cancer	0.000587	0.00081	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PSMA4—liver cancer	0.000587	0.00081	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—JUN—liver cancer	0.000581	0.000801	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CDKN1B—liver cancer	0.000577	0.000796	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—F2—liver cancer	0.000577	0.000796	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CTNNB1—liver cancer	0.000577	0.000795	CbGpPWpGaD
Olopatadine—Nausea—Doxorubicin—liver cancer	0.00057	0.00222	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—AKT1—liver cancer	0.000569	0.000785	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CDKN1A—liver cancer	0.000564	0.000777	CbGpPWpGaD
Olopatadine—S100A12—Immune System—BCL2L1—liver cancer	0.000563	0.000777	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CHN2—liver cancer	0.000555	0.000764	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000551	0.00076	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—MAPK8—liver cancer	0.00055	0.000758	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—JUN—liver cancer	0.00055	0.000758	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CTNNB1—liver cancer	0.000545	0.000752	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MAPK14—liver cancer	0.000533	0.000735	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CDKN1A—liver cancer	0.000533	0.000734	CbGpPWpGaD
Olopatadine—S100B—Immune System—BCL2L1—liver cancer	0.000533	0.000734	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000525	0.000723	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—MAPK8—liver cancer	0.00052	0.000717	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—liver cancer	0.000516	0.000712	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IFT88—liver cancer	0.000507	0.000699	CbGpPWpGaD
Olopatadine—S100B—Immune System—MAPK14—liver cancer	0.000504	0.000695	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.0005	0.000689	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDH1—liver cancer	0.000455	0.000627	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PRKCE—liver cancer	0.000455	0.000627	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CD—liver cancer	0.000435	0.000599	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—KRAS—liver cancer	0.000432	0.000595	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IGF2—liver cancer	0.000431	0.000594	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDH1—liver cancer	0.00043	0.000593	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—TRIO—liver cancer	0.000429	0.000592	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR4—liver cancer	0.000412	0.000567	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CD—liver cancer	0.000411	0.000567	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—KRAS—liver cancer	0.000408	0.000563	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000408	0.000562	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CSF2—liver cancer	0.000403	0.000555	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000402	0.000554	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—H2AFX—liver cancer	0.000397	0.000547	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PIK3CA—liver cancer	0.000397	0.000547	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—TRIO—liver cancer	0.00039	0.000537	CbGpPWpGaD
Olopatadine—S100A12—Immune System—RAF1—liver cancer	0.000388	0.000535	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	0.000388	0.000534	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.000382	0.000527	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MTOR—liver cancer	0.000379	0.000522	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CB—liver cancer	0.000379	0.000522	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PIK3CA—liver cancer	0.000375	0.000517	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000374	0.000516	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR4—liver cancer	0.000374	0.000515	CbGpPWpGaD
Olopatadine—S100B—Immune System—RAF1—liver cancer	0.000367	0.000506	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—HRAS—liver cancer	0.000367	0.000506	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TERT—liver cancer	0.000359	0.000495	CbGpPWpGaD
Olopatadine—S100B—Immune System—MTOR—liver cancer	0.000358	0.000494	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CB—liver cancer	0.000358	0.000494	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDKN1B—liver cancer	0.000356	0.00049	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—liver cancer	0.000351	0.000484	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2—liver cancer	0.000348	0.00048	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—HRAS—liver cancer	0.000347	0.000478	CbGpPWpGaD
Olopatadine—S100A12—Immune System—JUN—liver cancer	0.000339	0.000467	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDKN1B—liver cancer	0.000336	0.000464	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000336	0.000463	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CTNNB1—liver cancer	0.000336	0.000463	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—liver cancer	0.000332	0.000458	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000332	0.000457	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2—liver cancer	0.000329	0.000454	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KDR—liver cancer	0.000328	0.000452	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDKN1A—liver cancer	0.000328	0.000452	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK14—liver cancer	0.000326	0.000449	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—AKT1—liver cancer	0.000324	0.000447	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MAPK8—liver cancer	0.00032	0.000442	CbGpPWpGaD
Olopatadine—S100B—Immune System—JUN—liver cancer	0.00032	0.000441	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ESR1—liver cancer	0.00032	0.000441	CbGpPWpGaD
Olopatadine—S100B—Immune System—CTNNB1—liver cancer	0.000318	0.000438	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—F2—liver cancer	0.000316	0.000436	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SHC3—liver cancer	0.000311	0.000428	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDKN1A—liver cancer	0.00031	0.000428	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000309	0.000426	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—AKT1—liver cancer	0.000306	0.000422	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000305	0.00042	CbGpPWpGaD
Olopatadine—S100B—Immune System—MAPK8—liver cancer	0.000303	0.000418	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APC—liver cancer	0.000302	0.000417	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CG—liver cancer	0.000302	0.000417	CbGpPWpGaD
Olopatadine—S100A12—Immune System—STAT3—liver cancer	0.000293	0.000404	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000293	0.000404	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—F2—liver cancer	0.000291	0.000401	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000289	0.000398	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—BRAF—liver cancer	0.000284	0.000392	CbGpPWpGaD
Olopatadine—S100B—Immune System—STAT3—liver cancer	0.000277	0.000382	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CD—liver cancer	0.000266	0.000366	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SERPINE1—liver cancer	0.000263	0.000362	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—PIK3CA—liver cancer	0.000258	0.000356	CbGpPWpGaD
Olopatadine—S100A12—Immune System—KRAS—liver cancer	0.000251	0.000347	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.000251	0.000346	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FST—liver cancer	0.000241	0.000333	CbGpPWpGaD
Olopatadine—S100B—Immune System—KRAS—liver cancer	0.000238	0.000328	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RAF1—liver cancer	0.000237	0.000327	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PRKCE—liver cancer	0.000237	0.000327	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MTOR—liver cancer	0.000232	0.000319	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CB—liver cancer	0.000232	0.000319	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CA—liver cancer	0.000231	0.000318	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.000231	0.000318	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TRIO—liver cancer	0.00023	0.000317	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR4—liver cancer	0.000221	0.000304	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—UGDH—liver cancer	0.000219	0.000302	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CA—liver cancer	0.000218	0.000301	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CDKN1B—liver cancer	0.000217	0.0003	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PRKCE—liver cancer	0.000215	0.000297	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HRAS—liver cancer	0.000214	0.000295	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.000213	0.000294	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CASP3—liver cancer	0.000213	0.000294	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2—liver cancer	0.000213	0.000293	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CSF2—liver cancer	0.00021	0.000289	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCND1—liver cancer	0.000207	0.000286	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JUN—liver cancer	0.000207	0.000285	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—EPT1—liver cancer	0.000206	0.000284	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CTNNB1—liver cancer	0.000205	0.000283	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—liver cancer	0.000205	0.000282	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.000204	0.000282	CbGpPWpGaD
Olopatadine—S100B—Immune System—HRAS—liver cancer	0.000202	0.000279	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—liver cancer	0.000201	0.000278	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CDKN1A—liver cancer	0.000201	0.000277	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK8—liver cancer	0.000196	0.00027	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TAT—liver cancer	0.000195	0.000269	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—liver cancer	0.000193	0.000267	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CSF2—liver cancer	0.00019	0.000262	CbGpPWpGaD
Olopatadine—S100A12—Immune System—AKT1—liver cancer	0.000189	0.00026	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—liver cancer	0.000181	0.000249	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—STAT3—liver cancer	0.000179	0.000247	CbGpPWpGaD
Olopatadine—S100B—Immune System—AKT1—liver cancer	0.000178	0.000246	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADAM17—liver cancer	0.000175	0.000241	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MYC—liver cancer	0.000166	0.000229	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—liver cancer	0.000166	0.000229	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—F2—liver cancer	0.000164	0.000227	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PSMA4—liver cancer	0.000164	0.000226	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PSMD10—liver cancer	0.000164	0.000226	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CG—liver cancer	0.000157	0.000217	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KRAS—liver cancer	0.000154	0.000212	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—F2—liver cancer	0.000149	0.000206	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CG—liver cancer	0.000143	0.000197	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CA—liver cancer	0.000141	0.000195	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CD—liver cancer	0.000138	0.000191	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—liver cancer	0.000137	0.000188	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CPT1B—liver cancer	0.000133	0.000183	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GLUL—liver cancer	0.000133	0.000183	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HRAS—liver cancer	0.000131	0.00018	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NR1H4—liver cancer	0.000128	0.000176	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKCE—liver cancer	0.000127	0.000175	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTA3—liver cancer	0.000126	0.000173	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CD—liver cancer	0.000126	0.000173	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—liver cancer	0.000125	0.000172	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CB—liver cancer	0.000121	0.000166	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF2—liver cancer	0.00012	0.000166	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKT1—liver cancer	0.000115	0.000159	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTA4—liver cancer	0.000115	0.000159	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CSF2—liver cancer	0.000112	0.000155	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—RAF1—liver cancer	0.000112	0.000155	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTA2—liver cancer	0.000112	0.000155	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—H2AFX—liver cancer	0.000111	0.000153	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2—liver cancer	0.000111	0.000153	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CB—liver cancer	0.00011	0.000151	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTA1—liver cancer	0.000108	0.000149	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NAT2—liver cancer	0.000107	0.000147	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALDOB—liver cancer	0.000103	0.000141	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2—liver cancer	0.000101	0.000139	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TERT—liver cancer	0.0001	0.000138	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CRABP1—liver cancer	9.78e-05	0.000135	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KDR—liver cancer	9.17e-05	0.000126	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK14—liver cancer	9.11e-05	0.000126	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ESR1—liver cancer	8.93e-05	0.000123	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—F2—liver cancer	8.82e-05	0.000122	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HPGDS—liver cancer	8.55e-05	0.000118	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APC—liver cancer	8.44e-05	0.000116	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CG—liver cancer	8.44e-05	0.000116	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—BRAF—liver cancer	7.94e-05	0.000109	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PSMA4—liver cancer	7.62e-05	0.000105	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PSMD10—liver cancer	7.62e-05	0.000105	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CD—liver cancer	7.42e-05	0.000102	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GOT2—liver cancer	7.41e-05	0.000102	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CA—liver cancer	7.35e-05	0.000101	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SERPINE1—liver cancer	7.34e-05	0.000101	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—KRAS—liver cancer	7.27e-05	0.0001	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2E1—liver cancer	6.97e-05	9.61e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CA—liver cancer	6.68e-05	9.2e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RAF1—liver cancer	6.63e-05	9.14e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYCS—liver cancer	6.52e-05	8.99e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MTOR—liver cancer	6.47e-05	8.92e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CB—liver cancer	6.47e-05	8.92e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GOT1—liver cancer	6.4e-05	8.82e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GGT1—liver cancer	6.4e-05	8.82e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HRAS—liver cancer	6.18e-05	8.52e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN1B—liver cancer	6.07e-05	8.37e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT1—liver cancer	6.01e-05	8.28e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CASP3—liver cancer	5.95e-05	8.2e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2—liver cancer	5.94e-05	8.19e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—liver cancer	5.91e-05	8.15e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCND1—liver cancer	5.79e-05	7.98e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JUN—liver cancer	5.78e-05	7.97e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTP1—liver cancer	5.75e-05	7.92e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CTNNB1—liver cancer	5.74e-05	7.91e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMOX1—liver cancer	5.67e-05	7.81e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—liver cancer	5.62e-05	7.75e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN1A—liver cancer	5.6e-05	7.72e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK8—liver cancer	5.47e-05	7.54e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT1—liver cancer	5.45e-05	7.52e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTM1—liver cancer	5.28e-05	7.28e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—liver cancer	5.05e-05	6.96e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP1A1—liver cancer	5.01e-05	6.9e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STAT3—liver cancer	5e-05	6.89e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MTHFR—liver cancer	4.67e-05	6.44e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MYC—liver cancer	4.65e-05	6.4e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—liver cancer	4.64e-05	6.39e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARA—liver cancer	4.58e-05	6.31e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KRAS—liver cancer	4.29e-05	5.92e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CA—liver cancer	3.94e-05	5.44e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CG—liver cancer	3.92e-05	5.41e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—liver cancer	3.82e-05	5.26e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARG—liver cancer	3.79e-05	5.22e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HRAS—liver cancer	3.65e-05	5.03e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—liver cancer	3.49e-05	4.81e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CD—liver cancer	3.45e-05	4.75e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—liver cancer	3.4e-05	4.69e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT1—liver cancer	3.22e-05	4.44e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CB—liver cancer	3.01e-05	4.14e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.83e-05	2.53e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKT1—liver cancer	1.5e-05	2.06e-05	CbGpPWpGaD
